International AIDS Vaccine Initiative:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:International AIDS Vaccine Initiative - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9306
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
International AIDS Vaccine Initiative (IAVI) is a not-for-profit organization that develops preventive HIV vaccine candidates. The organization offers vaccine development through basic research, discovery, preclinical evaluation and manufacturing, and regulatory review, among others. Its products include mRNA-NFL, BG505 Envelope, eOD Immunogen, AAV-PG9, AD26, MVA, protein and CDV replicating vector, among others. IAVI conducts vaccine trials and related epidemiological research in partnership with academic, biotechnology, pharmaceutical and governmental institutions. The organization partners with government agencies, civil society, clinical, research institutions. It has operations across South Africa, Kenya, India, the US, and the Netherlands. IAVI is headquartered in New York, the US.

International AIDS Vaccine Initiative – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
International AIDS Vaccine Initiative, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
International AIDS Vaccine Initiative, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
International AIDS Vaccine Initiative, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
International AIDS Vaccine Initiative, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
International AIDS Vaccine Initiative, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
International AIDS Vaccine Initiative, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
International AIDS Vaccine Initiative Acquires Clinical Programs and Assets from Aeras TB Vaccine 10
Partnerships 11
IAVI and Serum Institute of India Enter into Development Partnership 11
International AIDS Vaccine Partners with CureVac 12
IAVI, GlycoMimetics, And Glycosensors and Diagnostics Enter Into Agreement To Develop AIDS Vaccine 13
Licensing Agreements 14
Valneva Enters Into Licensing Agreement With International AIDS Vaccine Initiative For HIV Vaccine 14
International AIDS Vaccine Initiative – Key Competitors 15
International AIDS Vaccine Initiative – Key Employees 16
International AIDS Vaccine Initiative – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Product News 18
05/31/2018: IAVI, Selexis SA and Collaborators Publish Study Highlighting Improved Approach for Generating Complex Proteins Required for Producing HIV Vaccines 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
International AIDS Vaccine Initiative, Pharmaceuticals & Healthcare, Key Facts 2
International AIDS Vaccine Initiative, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
International AIDS Vaccine Initiative, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
International AIDS Vaccine Initiative, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
International AIDS Vaccine Initiative, Deals By Therapy Area, 2012 to YTD 2018 8
International AIDS Vaccine Initiative, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
International AIDS Vaccine Initiative Acquires Clinical Programs and Assets from Aeras TB Vaccine 10
IAVI and Serum Institute of India Enter into Development Partnership 11
International AIDS Vaccine Partners with CureVac 12
IAVI, GlycoMimetics, And Glycosensors and Diagnostics Enter Into Agreement To Develop AIDS Vaccine 13
Valneva Enters Into Licensing Agreement With International AIDS Vaccine Initiative For HIV Vaccine 14
International AIDS Vaccine Initiative, Key Competitors 15
International AIDS Vaccine Initiative, Key Employees 16
International AIDS Vaccine Initiative, Other Locations 17

List of Figures
International AIDS Vaccine Initiative, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
International AIDS Vaccine Initiative, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
International AIDS Vaccine Initiative, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
International AIDS Vaccine Initiative, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
International AIDS Vaccine Initiative, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
International AIDS Vaccine Initiative, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
International AIDS Vaccine Initiative, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
International AIDS Vaccine Initiative, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[International AIDS Vaccine Initiative:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Knight Therapeutics Inc (GUD):企業財務及び戦略的SWOT分析
    Summary Knight Therapeutics Inc (Knight Therapeutics) is a speciality pharmaceutical company that focuses on acquisition, in-licensing, selling and marketing innovative over-the-counter and prescription products. Its product portfolio offers prescription drugs, consumer health products and medical d …
  • Healthsense Inc:医療機器:M&Aディール及び事業提携情報
    Summary Healthsense Inc (Healthsense), a subsidiary of GreatCall Inc is a medical device company that provides remote monitoring services. The company offers technology-enabled care solutions, aging technology services, for the entire senior care continuum. Its products include eNeighbor remote moni …
  • Yamana Gold Inc.:企業のM&A・事業提携・投資動向
    Yamana Gold Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Yamana Gold Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • Fortinet Inc (FTNT):企業の財務・戦略的SWOT分析
    Fortinet Inc (FTNT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Syndax Pharmaceuticals Inc (SNDX):企業財務及び戦略的SWOT分析
    Summary Syndax Pharmaceuticals Inc (Syndax) is a biopharmaceutical company that develops and commercializes epigenetic therapies for treatment-resistant cancers. The company is developing entinostat, which is an oral, small molecule drug candidate, which has direct effects on both cancer cells and i …
  • Seadrill Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Seadrill Limited Mergers and Ac …
  • Tokmanni Group Oyj (TOKMAN):企業の財務・戦略的SWOT分析
    Tokmanni Group Oyj (TOKMAN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Xtract Resources Plc (XTR):企業の財務・戦略的SWOT分析
    Summary Xtract Resources Plc (Xtract Resources), formerly Xtract Energy plc is a mining and mineral exploration and development company that offers mineral resources. The company acquires, explores, manages, operates, produces, mines, extracts, and develops gold and mineral resource deposit properti …
  • Kingold Jewelry, Inc. (KGJI):企業概要、財務及び戦略的SWOT分析
    Summary Kingold Jewelry, Inc. (Kingold) is a jewelry manufacturer. The company designs, manufactures and sells jewelry. Its products include gold necklaces, rings, earrings, bracelets, pendants, gifts and gold bars. Kingold sells products to wholesale and retail customers across China. The company s …
  • Millennium and Copthorne Hotels plc:企業概要・SWOT・財務分析
    Summary Canadean's "Millennium and Copthorne Hotels plc : Travel and Tourism - Company Profile, SWOT and Financial Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, bu …
  • DiscGenics Inc-製薬・医療分野:企業M&A・提携分析
    Summary DiscGenics Inc (DiscGenics) is a biotechnology company that develops advanced spinal therapeutics. The company develops therapies to treat patients with intervertebral disc diseases. Its products comprise Injectable Discogenic Cell Therapy (IDCT), developed for treating patients with moderat …
  • CSA Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary CSA Medical Inc (CSA Medical) is a medical device company that offers cryotherapy devices. The company provides spray cryotherapy medical device solutions to simplify procedures, improve patient outcomes, and reduce the cost of healthcare. Its truFreeze system delivers cold liquid nitrogen s …
  • Cabot Corporation (CBT):企業財務及び戦略的SWOT分析
    Cabot Corporation (CBT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Serodus ASA (RLMD)(製薬・医療分野):企業M&A動向
    Summary Serodus ASA (Serodus) is a drug development company. It undertakes the development of novel therapeutic products for the treatment of cardiovascular diseases with unmet medical needs. The company focuses on developing treatments for acute myocardial infarction, isolated systolic hypertension …
  • Mercadona SA:企業の戦略・SWOT・財務分析
    SummaryMercadona SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findings - …
  • PetroChina Co Ltd (857):企業の財務・戦略的SWOT分析
    PetroChina Co Ltd (857) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • HealthLinx Limited (formerly Cryptome Pharmaceuticals Limited):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' HealthLinx Limited (formerly Cr …
  • Vallourec SA:企業の戦略・SWOT・財務情報
    Vallourec SA - Strategy, SWOT and Corporate Finance Report Summary Vallourec SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Immunocore Limited(製薬・医療分野):企業M&A動向
    Summary Immunocore limited (Immunocore) is a biotechnology company. The company develops biological therapeutics for the treatment of cancer and a range of other serious diseases. It develops ImmTAC reagents for a number of molecular targets applicable to the treatment of a range of clinical indicat …
  • Jordan Health Services, Inc.(製薬・医療分野):企業M&A動向
    Summary Jordan Health Services, Inc. (Jordan Health) is a healthcare center. The center provides home health services to pediatric and adult patients. Its services include home health services, personal care, home management, and pediatric and skilled nursing to medicaid and medicare eligible patien …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆